Prospective Decision Impact Trial of KidneyIntelX

Clinical trial NCT04960514 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04960514
Sponsor: Renalytix AI, Inc.
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Diabetic Kidney Disease Chronic Kidney Disease Stage 1 Chronic Kidney Disease Stage 2 Chronic Kidney Disease, Stage 3 (Moderate)

Start date: 2021-11-22
Primary completion: 2023-12-01
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.